CLINICAL_TRIALS ClinicalTrials.gov record update

Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Activity on the "Receptor Activator of Nuclear Factor-kappa B Ligand / Osteoprotégérine (RANKL / OPG) System in Patients Living With Type II Diabetes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04893135
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:18.742785+00:00
Published At: 2023-02-16T00:00:00+00:00
Record Updated At: 2023-02-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Type II Diabetes"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-02-16"
protocolSection.identificationModule.nctId: "NCT04893135"
protocolSection.identificationModule.officialTitle: "Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Activity on the \"Receptor Activator of Nuclear Factor-kappa B Ligand / Osteoprot\u00e9g\u00e9rine (RANKL / OPG) System in Patients Living With Type II Diabetes"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.